Available online at: 158 Swolverine
A Mediterranean diet, abundant in these healthy fats, has been shown to lower cardiovascular risk significantly
The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication
The effects are typically more modest but can be meaningful, particularly when combined with other healthy habits
GLP-1 Agonists and Gastric Motility: The Core Connection As weve discussed, Zepbound (tirzepatide) works, in part, by slowing gastric emptying